Tirzepatide may confer larger increases in testosterone levels among men with metabolic hypogonadism than testosterone ...

Men receiving tirzepatide showed greater reductions in body weight and waist circumference and improvements in erectile ...

Tirzepatide was superior to semaglutide in achieving standard and intensive cardiometabolic targets among patients with type 2 diabetes.

On its clinic website, the supermarket chain said the self-injectable pens can be used once a week to increase a user’s chance of sustained weight loss, amounted to around 20% of their bodyweight in a ...

A new study reports that GLP-1 medications may improve low testosterone in men with obesity or type 2 diabetes. The findings ...

ZEPBOUND ™ KwikPen ® is the first and only Health Canada-approved treatment activating two incretin hormone receptors, GIP and GLP-1, to manage obesity or overweight Adults taking tirzepatide ...

Study Overview: Eli Lilly and Company is conducting a study titled ‘Efficacy and Safety of Tirzepatide Once Weekly Versus Placebo for the Treatment of Obesity and Weight-Related Comorbidities in ...

The primary outcome assessed was a diagnosis of erectile dysfunction or the initiation of phosphodiesterase type 5 (PDE-5) inhibitor therapy, which is commonly used to treat ED. The study yielded the ...

Assessment of sexual dysfunction among adult male survivors of childhood cancer has primarily been limited to erectile dysfunction. This study aimed to characterize sexual functioning more ...

For adults with obesity or overweight, tirzepatide-linked improvements in cardiometabolic risk factors are associated with the degree of weight reduction, according to a study published online ...

In this study, a patient with tirzepatide was delayed due to delayed gastric emptying, resulting in gastrointestinal tract clearance during the procedure. In a retrospective study of patients who ...